Kinetic characterization of secretory transport of a new ciprofloxacin derivative (CNV97100) across Caco-2 cell monolayers.
Kinetic characterization of secretory transport of a new ciprofloxacin derivative (CNV97100) across Caco-2 cell monolayers.
复制标题
新型环丙沙星衍生物 (CNV97100) 跨 Caco-2 细胞单层分泌转运的动力学表征。
DOI:
10.1002/jps.10244
复制
发表时间:
2002
期刊:
影响因子:
--
通讯作者:
Hu,Ming
中科院分区:
文献类型:
--
作者:
Ruiz-Garcia,Ana;Lin,Huimin;Pla-Delfina,JoseM;Hu,Ming
The kinetics of transport of a new fluoroquinolone antibiotic (CNV97100) and its analogs were characterized using the Caco-2 cell culture model. Unidirectional permeabilities of these analogs were greater (p< 0.05) than that of ciprofloxacin. The absorptive permeabilities (PAB) of 4′-N-substituted analogs (CNV97101-104) were 400–600% greater, whereas the secretory permeability (PBA) was 25–80% greater than unsubstituted analogs because CNV97101-104 were poor substrates for efflux transporters (efflux ratio ≈ 1). The transport of compounds without 4′-N-substitution (i.e., ciprofloxacin and CNV97100) favored secretion (efflux ratio ≈ 4). Further characterization of CNV97100 transport revealed that it was concentration dependent (apparentKm= 0.484 mM, and apparentVmax= 17.5 nmol · cm−2· h−1), and temperature dependent (Ea= 20.57 forPABand 31.45 kcal/mol forPBA, respectively).p-Glycoprotein (p-gp)inhibitors, such as verapamil (100 μM) and cyclosporin A (CsA, 20 μM) significantly (p< 0.05) inhibitedPBAbut significantly (p< 0.05) enhancedPAB. Multidrug resistance related protein (MRP) inhibitor leukotriene C4only decreased (p< 0.05)PBAof ciprofloxacin but not that of CNV97100. In the presence of increasing concentrations of verapamil, thePBAof CNV97100 decreased significantly (p< 0.05), with an IC90value of 96.5 μM. Taken together, these results suggested that 4′-N-alkylation of fluoroquinolones improves their absorptive permeability. Secretion of CNV97100 is dominated byp-gp, whereas the secretion of ciprofloxacin is via a combination of efflux transporters. © 2002 Wiley-Liss, Inc. and the American Pharmaceutical Association